Qurient Co., Ltd. (KOSDAQ:115180)
22,500
-450 (-1.96%)
At close: Sep 9, 2026
Qurient Market Cap
Qurient has a market cap or net worth of 914.95 billion as of September 9, 2026. Its market cap has increased by 91.14% in one year.
Market Cap
914.95B
Enterprise Value
898.37B
Revenue
7.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,500.00
ChartMarket Cap Chart
Since February 29, 2016, Qurient's market cap has increased from 281.86B to 914.95B, an increase of 224.61%. That is a compound annual growth rate of 11.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 914.95B | -22.81% |
| Dec 30, 2025 | 1.19T | 674.51% |
| Dec 30, 2024 | 153.05B | 69.38% |
| Dec 28, 2023 | 90.36B | -24.77% |
| Dec 29, 2022 | 120.11B | -63.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.57T |
| JS Link | 1.13T |
| Rznomics | 798.41B |
| AprilBio | 500.12B |
| ROKIT Healthcare | 469.70B |
| Curocell | 365.45B |
| Inventage Lab | 348.66B |
| HansBiomed | 279.52B |